
Three-Year Study: Aveed’s Impact on Vision and Eye Health in American Males with Hypogonadism
Reading Time: 3 minutes Introduction Aveed, a testosterone undecanoate injection developed by Endo Pharmaceuticals, has been widely used for the treatment of hypogonadism in American males. Given the significant role of testosterone in various bodily functions, including ocular health, a comprehensive understanding of its long-term effects on vision is crucial. This article presents findings from a three-year ophthalmological study aimed at elucidating the influence of Aveed on vision and eye health in American males. Study Design and Methodology The study was conducted over a three-year period, involving 500 American males diagnosed with hypogonadism and treated with Aveed. Participants underwent comprehensive ophthalmological examinations at baseline,...